Stratified Analysis of Patients Within the PSA Gray Zone (4-10 ng/mL) and Its Clinical Application Value: Development of a Predictive Model for Clinically Significant Prostate Cancer Using Quantitative Indicators of PSA, ADC, and Relative T2 Value. [PDF]
Diagnostics (Basel)Hao P, Zhu T, Xin R, Lv X.
europepmc +1 more source
Multi-regional Multiparametric Deep Learning Radiomics for Diagnosis of Clinically Significant Prostate Cancer. [PDF]
J Imaging Inform MedLiu X +5 more
europepmc +1 more source
Patients with Marked Prostatomegaly and Clinically Significant Prostate Cancer Have Inferior Perioperative Outcomes Following Radical Prostatectomy. [PDF]
J Clin MedMorgan TN +9 more
europepmc +1 more source
Impact of commonly used medications on the detection of clinically significant prostate cancer in the targeted biopsy era. [PDF]
Am J Clin Exp UrolBrackman KN +5 more
europepmc +1 more source
Development and external validation of nomograms for predicting prostate cancer and clinically significant prostate cancer in patients with PSA between 4 and 20 ng/mL. [PDF]
BMC UrolWu K +7 more
europepmc +1 more source
Related searches:
Genetic testing in prostate cancer management: Considerations informing primary care
Ca-A Cancer Journal for Clinicians, 2022Mary-Ellen Taplin +2 more
exaly
Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer
Ca-A Cancer Journal for Clinicians, 2016Peter A Pinto +2 more
exaly
Expectant management for men with early stage prostate cancer
Ca-A Cancer Journal for Clinicians, 2015Christopher Filson
exaly
Progress and controversies: Radiation therapy for prostate cancer
Ca-A Cancer Journal for Clinicians, 2014Neil E Martin
exaly